Nbcd A/S
Public limited companyCVR 30582462SøborgActive
Nbcd A/S is a public limited company, based in Søborg, active in research and experimental development on natural sciences and engineering, founded in 2007. Net profit fell 82% from 2024 to 2025, ending at DKK 9.2m. With 21 employees, the company is about 4 times larger than the industry median. Equity fell to DKK 136.1m in 2025.
Key figures · financial year 2025
What has changed
calculated from recorded figures and datesFinancials: 2025 against 2024
- Gross profit fell 72% (2024 → 2025), to DKK 31.6m.
- Net profit fell 82% (2024 → 2025), to DKK 9.2m.
- Equity fell 23% (2024 → 2025), to DKK 136.1m.
Employees
- 8 fewer employees than a year earlier: 21 (08/2026) against 29 (08/2025).
Management and owners, last 24 months
- New in management: Mark Høgh Gandrup (director, 01/01/2026), Pierre Khaitrine (chair of the board, 29/07/2026) and José Ignacio Pfeifer (board member, 29/07/2026).
- Stepped down: Karl Sebastian Inger (chair of the board, 29/07/2026), Jakob Brix Christensen (director, 31/12/2025) and Pierre Khaitrine (board member, 28/07/2026).
Registrations, last 24 months
- 01/01/2025: Industry changed to Research and experimental development on natural sciences and engineering (721000)
Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.
Financial statements
Financial years 2020–2025 · amounts in DKK thousandEquity and net profit
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change | |
|---|---|---|---|---|---|---|---|
| Revenue | not stated | not stated | not stated | not stated | not stated | not stated | – |
| Gross profit | 59,689 | 60,449 | 94,669 | 133,709 | 111,160 | 31,583 | −71.6% |
| Operating profit (EBIT) | 52,716 | 47,245 | 69,764 | 88,510 | 66,389 | −22,305 | −133.6% |
| Profit before tax | 51,715 | 44,862 | 70,425 | 92,160 | 67,472 | 16,554 | −75.5% |
| Net profit | 40,503 | 35,649 | 45,857 | 70,806 | 52,621 | 9,223 | −82.5% |
| Total assets | 125,045 | 192,311 | 236,619 | 302,513 | 306,970 | 340,184 | +10.8% |
| Equity | 71,989 | 107,638 | 123,495 | 194,301 | 176,922 | 136,145 | −23% |
| Liabilities | 53,055 | 84,673 | 113,125 | 108,212 | 130,048 | 204,039 | +56.9% |
| Cash and cash equivalents | 8,373 | 52,915 | 95,503 | 120,824 | 65,264 | 26,591 | −59.3% |
| Average number of employees | 23 | 26 | 31 | 40 | 46 | 33 | −28.3% |
Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2020, 2021, 2022, 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.
Download the figures as CSV · free with an account, amounts in whole DKK
Signals from the financial statements
calculated from the 2025 figuresFewer employees
The number of employees fell 28% from 46 in 2024 to 33 in 2025.
How is this calculated?
The number of employees according to the annual report has fallen by at least 25%, and was at least 10 the year before.
Profit for five years in a row
Net result has been positive in 2021–2025.
How is this calculated?
Net result is positive in the five latest annual reports in a row.
The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.
Annual reports
6 financial years| Financial year | Period | Published | Figures for | Documents |
|---|---|---|---|---|
| 2025 | 01/01/2025 – 31/12/2025 | 03/06/2026 | The company | PDF not statedXBRL |
| 2024 | 01/01/2024 – 31/12/2024 | 14/05/2025 | The company | PDFXBRL |
| 2023 | 01/01/2023 – 31/12/2023 | 24/05/2024 | The company | PDFXBRL |
| 2022 | 01/01/2022 – 31/12/2022 | 26/05/2023 | The company | PDFXBRL |
| 2021 | 01/01/2021 – 31/12/2021 | 18/05/2022 | The company | PDFXBRL |
| 2020 | 01/01/2020 – 31/12/2020 | 07/05/2021 | The company | PDFXBRL |
The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.
Employees
monthly figures from CVRPosition in the industry
431 companies in the databaseComparison with the other companies in research and experimental development on natural sciences and engineering based on the latest financial year.
Industry median: gross profit DKK 616k, net profit −DKK 892k, equity DKK 2m, 5 employees.
Compared with similar companies
size, age and company form| Group | Gross profit | Equity |
|---|---|---|
| Companies with 20–49 employees9,922 companies in the comparison | No. 1,223of 9,892 Better than 88% | No. 266of 9,922 Better than 97% |
| Same industry and 20–49 employees64 companies in the comparison | No. 9of 62 Better than 87% | No. 11of 64 Better than 84% |
| Companies that are between 15 and 29 years old24,910 companies in the comparison | No. 2,247of 24,791 Better than 91% | No. 1,062of 24,909 Better than 96% |
| All companies of type A/S18,025 companies in the comparison | No. 4,232of 17,786 Better than 76% | No. 1,860of 18,024 Better than 90% |
The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.
Compare with the industry
Research and experimental development on natural sciences and engineering- Nbcd A/SDKK 31.6m
- Carlsberg A/SDKK 40.2bn
- Zealand Pharma A/SDKK 9.2bn
- Nbcd A/SDKK 9.2m
- Carlsberg A/SDKK 7bn
- Zealand Pharma A/SDKK 6.5bn
- Nbcd A/SDKK 136.1m
- Carlsberg A/SDKK 30.7bn
- Zealand Pharma A/SDKK 14.8bn
- Nbcd A/S21
- Carlsberg A/S107
- Zealand Pharma A/S569
Latest financial year per company. Choose up to three companies from the largest in the industry.
Owners and group
from the Public Ownership Register- Sanos Holding A/S100%
Management
5 active registrationsExecutive management
| Name | Role | Appointed |
|---|---|---|
| Jeppe Ragnar Andersen | CEO | 01/01/2014 |
| Mark Høgh Gandrup | Director | 01/01/2026 |
Board of directors
| Name | Role | Appointed |
|---|---|---|
| Jeppe Ragnar Andersen | Board member | 10/12/2020 |
| Pierre Khaitrine | Chair of the board | 29/07/2026 |
| José Ignacio Pfeifer | Board member | 29/07/2026 |
- Founders
- Nordic Bioscience Clinical Studies A/S
Former management (13)
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| Claus Henrik Christiansen | Chair of the board | 07/05/2007 | 10/12/2020 |
| Bente Juel Christiansen | Board member | 07/05/2007 | 03/12/2010 |
| Thomas Nielsen | Director | 07/05/2007 | 03/12/2010 |
| Morten Asser Karsdal | Board member | 07/05/2007 | 01/07/2020 |
| Bente Juel Christiansen | Director | 03/12/2010 | 01/01/2014 |
| Thomas Nielsen | Board member | 03/12/2010 | 10/12/2020 |
| Bente Juel Christiansen | Board member | 01/07/2020 | 10/12/2020 |
| Henrik Bernt Sanders | Board member | 01/07/2020 | 10/12/2020 |
| Celine Infeld | Board member | 10/12/2020 | 31/01/2024 |
| Karl Sebastian Inger | Chair of the board | 10/12/2020 | 29/07/2026 |
| Henning Heiberg Andersen | Director | 13/12/2021 | 31/01/2024 |
| Jakob Brix Christensen | Director | 31/01/2024 | 31/12/2025 |
| Pierre Khaitrine | Board member | 31/01/2024 | 28/07/2026 |
Signing rule: Selskabet tegnes af to bestyrelsesmedlemmer i forening, af et bestyrelsesmedlem og en direktør i forening, af to direktører i forening eller af den samlede bestyrelse i forening.
Address and production units
1 active production unitsTelefonvej 8D
2860 Søborg
Gladsaxe Municipality · Postcode 2860
Other companies at the address (2)
- Sanos Group ApSOther activities auxiliary to financial services, except insurance and pension funding
- NeuroScios A/SResearch and experimental development on natural sciences and engineering
| Production unit | Address | Employees | P number |
|---|---|---|---|
| NBCD A/S | Telefonvej 8D, 2, 2860 Søborg | 21 | 1013268114 |
Purpose
Selskabets formål er at drive virksomhed indenfor bioteknologi og anden dermed i forbindelse stående virksomhed.
The purpose is quoted from the register in Danish.
Changes year by year
51 registered events20266 changesmanagement 5 · accounts 1
- ManagementJosé Ignacio Pfeifer appointed board member
- ManagementPierre Khaitrine appointed chair of the board
- ManagementKarl Sebastian Inger stepped down as chair of the board
- ManagementPierre Khaitrine stepped down as board member
- AccountsAnnual report for 2025 published
- ManagementMark Høgh Gandrup appointed director
20253 changesmanagement 1 · accounts 1 · industry 1
- ManagementJakob Brix Christensen stepped down as director
- AccountsAnnual report for 2024 published
- IndustryIndustry changed to Research and experimental development on natural sciences and engineering (721000)
20245 changesaccounts 1 · management 4
- AccountsAnnual report for 2023 published
- ManagementPierre Khaitrine appointed board member
- ManagementJakob Brix Christensen appointed director
- ManagementHenning Heiberg Andersen stepped down as director
- ManagementCeline Infeld stepped down as board member
20233 changesaccounts 1 · address 2
- AccountsAnnual report for 2022 published
- AddressMoved to Telefonvej 8D, 2, 2860 Søborg
- AddressMoved to Telefonvej 8D, 2, 2860 Søborg
20222 changesaddress 1 · accounts 1
- AddressMoved to Telefonvej 8D, 2, 2860 Søborg
- AccountsAnnual report for 2021 published
20212 changesmanagement 1 · accounts 1
- ManagementHenning Heiberg Andersen appointed director
- AccountsAnnual report for 2020 published
202013 changesmanagement 10 · name 1 · ownership 2
- ManagementKarl Sebastian Inger appointed chair of the board
- ManagementCeline Infeld appointed board member
- ManagementJeppe Ragnar Andersen appointed board member
- ManagementBente Juel Christiansen stepped down as board member
- ManagementHenrik Bernt Sanders stepped down as board member
- ManagementThomas Nielsen stepped down as board member
- ManagementClaus Henrik Christiansen stepped down as chair of the board
- NameName changed from NORDIC BIOSCIENCE CLINICAL DEVELOPMENT A/S to NBCD A/S
- ManagementBente Juel Christiansen appointed board member
- ManagementHenrik Bernt Sanders appointed board member
- ManagementMorten Asser Karsdal stepped down as board member
- OwnershipSanos Holding A/S registered as owner (100%)
- OwnershipNORDIC BIOSCIENCE HOLDING A/S is no longer registered as owner
20191 changeaddress 1
- AddressMoved to Herlev Hovedgade 82, 2730 Herlev
20181 changeaddress 1
- AddressMoved to Herlev Hovedgade 205, 2730 Herlev
20142 changesmanagement 2
- ManagementJeppe Ragnar Andersen appointed ceo
- ManagementBente Juel Christiansen stepped down as director
20107 changesaddress 1 · name 1 · industry 1 · management 4
- AddressMoved to Herlev Hovedgade 207, 2730 Herlev
- NameName changed from NORDIC BIOSCIENCE PROJECT 2 A/S to NORDIC BIOSCIENCE CLINICAL DEVELOPMENT A/S
- IndustryIndustry changed to Forskning og eksperimentel udvikling indenfor bioteknologi (721100)
- ManagementThomas Nielsen appointed board member
- ManagementBente Juel Christiansen appointed director
- ManagementThomas Nielsen stepped down as director
- ManagementBente Juel Christiansen stepped down as board member
20076 changesownership 1 · founded 1 · management 4
- OwnershipNORDIC BIOSCIENCE HOLDING A/S registered as owner (100%)
- FoundedRegistered as NORDIC BIOSCIENCE PROJECT 2 A/S
- ManagementThomas Nielsen appointed director
- ManagementBente Juel Christiansen appointed board member
- ManagementMorten Asser Karsdal appointed board member
- ManagementClaus Henrik Christiansen appointed chair of the board
Related companies
Same industry in Gladsaxe
- Zealand Pharma A/S569 employees
- Fortrea Denmark ApS31 employees
- Fida Biosystems ApS23 employees
- Kvasir Technologies ApS21 employees
- Chromologics ApS19 employees
- Cellugy ApS18 employees
Same people in management
- Anders Nielsen & Co A/Svia Henrik Bernt Sanders
- Nordic Bioscience A/Svia Bente Juel Christiansen
- Uma Film ApSvia Henrik Bernt Sanders
- Mazanti-andersen Advokatpartnerselskabvia Henrik Bernt Sanders
- Origio A/Svia Jakob Brix Christensen
- Unibio A/Svia Jakob Brix Christensen
Largest in the industry
- Carlsberg A/SDKK 40.2bn
- Zealand Pharma A/SDKK 9.2bn
- Gubra A/SDKK 2.6bn
- Vestas Wind Systems A/SDKK 2.5bn
- Bang & Olufsen A/SDKK 1.4bn
- 3shape A/SDKK 1.3bn
Source and updates
The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.